...
首页> 外文期刊>Pharmaceutics >Acyclovir-Loaded Chitosan Nanospheres from Nano-Emulsion Templating for the Topical Treatment of Herpesviruses Infections
【24h】

Acyclovir-Loaded Chitosan Nanospheres from Nano-Emulsion Templating for the Topical Treatment of Herpesviruses Infections

机译:从纳米乳剂模板中加载无环鸟苷的壳聚糖纳米球用于疱疹病毒感染的局部治疗

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Acyclovir is not a good candidate for passive permeation since its polarity and solubility limit is partitioning into the stratum corneum. This work aims to develop a new topical formulation for the acyclovir delivery. New chitosan nanospheres (NS) were prepared by a modified nano-emulsion template method. Chitosan NS were characterized by Dynamic Light Scattering (DLS), Transmission Electron Microscopy (TEM), and an in vitro release study. The in vitro skin permeation experiment was carried out using Franz cells and was equipped with porcine skin. Biological studies were performed on the Vero cell line infected by HSV-1 and HSV-2 strains. The acyclovir loaded chitosan NS appeared with a spherical shape, a size of about 200 nm, and a negative zeta potential of about 40.0 mV. The loading capacity of the drug was about 8.5%. In vitro release demonstrated that the percentage of acyclovir delivered from the nanospheres was approximately 30% after six hours. The in vitro skin permeation studies confirmed an improved amount of permeated acyclovir. The acyclovir-NS complex displayed a higher antiviral activity than that of free acyclovir against both the HSV-1 and the HSV-2 strain. The acyclovir-loaded NS showed no anti-proliferative activity and no signs of cytotoxicity induced by NS was detected. Confocal laser scanning microscopy confirmed that the NS are taken up by the cells.
机译:阿昔洛韦不是被动渗透的好选择,因为它的极性和溶解度极限正在分配到角质层中。这项工作旨在为无环鸟苷开发一种新的局部用药。通过改进的纳米乳液模板法制备了新的壳聚糖纳米球(NS)。壳聚糖NS的特点是动态光散射(DLS),透射电子显微镜(TEM)和体外释放研究。使用Franz细胞进行体外皮肤渗透实验,并配备猪皮肤。对被HSV-1和HSV-2株感染的Vero细胞系进行了生物学研究。载有阿昔洛韦的壳聚糖NS呈球形,大小约为200 nm,负ζ电势约为40.0 mV。该药物的负载量为约8.5%。体外释放表明,从纳米球中递送的阿昔洛韦百分比在六个小时后约为30%。体外皮肤渗透研究证实,阿昔洛韦的渗透量有所提高。无环鸟苷-NS复合物显示出比游离无环鸟苷对HSV-1和HSV-2菌株更高的抗病毒活性。载有阿昔洛韦的NS没有显示出抗增殖活性,也未检测到由NS诱导的细胞毒性迹象。共聚焦激光扫描显微镜证实NS被细胞吸收。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号